Nox Medical

Name

Nox Medical

Legal name

Nox Medical

Website

https://noxmedical.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Sleep Diagnostic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB)

akta.pro secondary industries

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)

Keywords

• Sleep diagnostic devices
• Polysomnography systems
• Home sleep testing
• Sleep medicine software
• Medical device manufacturing

Headquarters

HQ city

Reykjavík

HQ country

Iceland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Sleep Diagnostic Hardware Sales: Nox Medical generates revenue primarily through the sale of sleep diagnostic hardware devices including the Nox A1s PSG system, Nox T3s home sleep testing device, Nox C1 access point, sensors, and accessories. Products are sold directly in the US and Canada and through distributors internationally.
2. Software Platform (Noxturnal): Revenue is generated from the Noxturnal software system used for data collection and analysis of sleep studies. Software is bundled with hardware systems and supports cloud connectivity for telehealth applications.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Nox Medical designs and manufactures portable polysomnography (PSG) systems and home sleep testing (HST) devices for sleep medicine professionals. Its product portfolio centers on the Nox A1s PSG System (for in-lab and ambulatory studies), the Nox T3s HST Device, and the Noxturnal Software System for data collection, scoring, and reporting. The company also offers accessories, connectivity solutions, and the experimental Self-Applied Somnography (SAS) configuration for research-grade at-home studies.

Product overview

Nox Medical offers a modular, integrated sleep diagnostics product portfolio centered on two core device lines: the Nox A1s PSG System (a portable polysomnography system for in-lab and at-home sleep studies) and the Nox T3s (a home sleep apnea testing device). These devices are supported by the Noxturnal Software System for data collection, analysis, and reporting, and Nox Connect/Nox C1 for cloud connectivity. The portfolio includes the Nox SAS (Self-Applied Somnography) configuration for self-applied at-home PSG studies, the Nox Home Sleep Testing Service for end-to-end HST delivery, and a range of Sensors & Accessories (including RIP belts and nasal cannula). System Extensions add wireless oximetry and pressure sensing capabilities. The ecosystem is complemented by the Somryst prescription digital therapeutic for insomnia. The products share a common hardware platform, Bluetooth-based body area network, and Noxturnal software, enabling a seamless continuum of care from hospital to home.

Differentiator

Problem solved

Functional benefit

Brands

• Nox Research: A dedicated team of scientists working within Nox Medical on advancing sleep medicine by bringing together developments in engineering, data science and AI, with medicine.
• Nox Academy
• Nox BodySleep
• Nox Self-Applied Somnography (SAS)
• Noxturnal
• Nox Connect
• Somryst

Products and services

• Nox A1s PSG System A full, portable polysomnography system that simplifies sleep study performance while delivering precise measurements. Features wireless Bluetooth body area network, hospital-to-home flexibility, telehealth capabilities, and supports in-lab and at-home studies. Sold to sleep labs, hospitals, and research institutions.
• Nox T3s HST Device Next-generation home sleep apnea testing device designed for at-home diagnostic use with disposable RIP belts and filtered nasal cannula. Combines clinical accuracy with simplicity for safe and hygienic home-based operation. Sold to sleep centers and healthcare providers.
• Noxturnal Software System Cloud-connected software platform for viewing, analyzing, scoring, and reporting sleep study data collected by Nox PSG and HST devices. Includes bio-calibration, impedance checks, live trace viewing, and signal quality review features. Sold to sleep professionals alongside hardware devices.
• Nox Connect Cloud-based connectivity solution that facilitates remote data transfer and access for Nox Medical diagnostic devices, enabling telehealth workflows and integration with the Nox SAS self-applied sleep studies.
• Nox C1 Access Point System access point that extends Nox diagnostic systems, providing additional connectivity and data transfer functionality for sleep study equipment.
• Nox SAS solution (Self-Applied Somnography) A configuration of the Nox A1s PSG system that enables patients to self-apply the diagnostic equipment at home without a sleep technician, using a frontal electrode montage designed for self-application. Available for research purposes only. Used by sleep researchers and clinical research organizations.
• Nox Home Sleep Testing Service End-to-end home sleep testing service offering that provides telehealth delivery and remote patient monitoring for at-home sleep apnea diagnostics, enabling healthcare providers to scale HST operations.
• Sensors & Accessories Range of sensors and accessories including Nox RIP belts (respiratory inductance plethysmography), disposable sensors, nasal cannula, and other components ensuring high-quality signals for sleep studies.
• System Extensions Components that extend Nox systems including wireless sensors such as the Nonin 3150 Oximeter with Bluetooth connectivity, differential pressure sensors for airflow prediction, and other spare/extension parts. Availability varies by market.

Quantifiable outcome

• 90.2% successful home polysomnography rate with 85% of successful studies rated excellent or very good signal quality
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability7 records

Feature10 records

Partnerships

Eleven partnerships are on record, tiered flagship, core and minor.

• Sleep Revolution Consortium (EU Horizon 2020)flagshipStrategic or Co-development Partner · 8 December 2020Nox Medical is one of nearly 40 collaborating partners in the Sleep Revolution interdisciplinary international research and development project, awarded a 15-million Euro grant from the EU Horizon 2020 Framework Programme. The project aims to revolutionize research, diagnosis, and treatment of obstructive sleep apnea (OSA) across 37+ centers in Europe and Australia over four years. Nox Medical contributes technical and scientific expertise through Nox Research and provides diagnostic devices for the project's sleep studies. Led by Dr. Erna Sif Arnardottir of Reykjavik University Sleep Institute.
• Reykjavik University Sleep InstitutecoreStrategic or Co-development PartnerLed by Dr. Erna Sif Arnardottir, the Reykjavik University Sleep Institute is the lead academic institution for the Sleep Revolution project. The institute collaborates with Nox Medical on research projects, including the use of Nox SAS and Nox diagnostic devices for large-scale sleep research.
• Harvard Medical School (Wellman & Sands)coreStrategic or Co-development PartnerNox Medical collaborated with Harvard Medical School professors Andrew Wellman and Scott Sands to reproduce and implement the Endo-Phenotyping Using Polysomnography (PUP) method. Nox Research developed the PUPpy Python implementation of the algorithm. This collaboration resulted in a breakthrough allowing extraction of four pathophysiological endo-phenotypes from standard PSG recordings.
• KTH Royal Institute of TechnologyminorStrategic or Co-development PartnerAcademic collaboration for end-to-end machine learning on raw EEG signals for sleep stage classification, co-authored with KTH University researchers.
• University of Miami / Miller School of Medicine (Dr. Naresh Punjabi)coreStrategic or Co-development PartnerDr. Naresh Punjabi, Chief of the Division of Pulmonary, Critical Care and Sleep Medicine at University of Miami, collaborated with Nox Medical to use the Nox SAS in the MACS (Multicenter AIDS Cohort Study) for at-home sleep studies in over 1,000 individuals. This demonstrated the feasibility of self-applied PSG for large-scale clinical research.
• China Medical University Hospital, Taiwan (Dr. Wan-Ju Cheng & Dr. Hang Liang Wen)minorStrategic or Co-development PartnerCollaboration with researchers from China Medical University in Taiwan to study endo-phenotyping of OSA patients using the PUPpy algorithm with Nox PSG data. Research examined how endo-phenotypes are associated with CPAP treatment outcomes and optimal titration pressure across 558+ patients.
• European Union Horizon 2020 Research & Innovation ProgrammeflagshipOthersThe EU Horizon 2020 Framework Programme awarded a 15-million Euro grant to the Sleep Revolution project. Nox Medical's participation in this project includes funding for developing machine learning techniques to better estimate OSA severity and treatment needs.
• Eurostars Funding ProgrammecoreOthersEurostars is a European funding programme that supports innovative SMEs and small mid-caps. Nox Research has received Eurostars funding for research projects.
• Icelandic Technology Development FundcoreOthersIcelandic Technology Development Fund has provided funding for Nox Research projects, supporting the company's innovation in sleep diagnostic technology.
• American Academy of Sleep Medicine (AAST)coreStrategic or Co-development PartnerNox Medical partnered with the AAST to organize the webinar 'Exploring Gender Disparities in Sleep Testing: Diagnosing Obstructive Sleep Apnea in Women.' AAST is the primary professional society for sleep technologists and collaborates on educational content.
• FusionSleepcoreStrategic or Co-development PartnerFusionSleep, an Atlanta-based sleep center operating two sleep centers with 12 beds, has collaborated with Nox Medical for years. They serve as a case study for using Nox T3 and Nox A1 devices in telehealth settings, demonstrating successful implementation of home sleep testing with telehealth during COVID-19.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Compumedics: Australia-based manufacturer of polysomnography (PSG) and home sleep testing (HST) systems, including the Somté and Somfit product lines. Compumedics is the closest direct peer to Nox Medical: same core offering (in-lab PSG + HST hardware + analysis software), same target customers (sleep labs, hospitals, researchers), and a comparable global distribution model.
• Natus Medical: US-based manufacturer of neurodiagnostic and sleep diagnostic devices, including PSG systems, EEG, and related neurology/sleep workflows. Highly comparable product portfolio and clinical customer base; was acquired by ArchiMed in 2022, providing a recent market validation point for the category.
• Itamar Medical (ZOLL Itamar): Israel-based developer of the WatchPAT home sleep apnea testing device, now part of ZOLL Medical. WatchPAT is one of the most clinically validated HST alternatives and competes head-to-head with Nox T3s/T3 in home sleep apnea testing, making Itamar a direct competitor for HST market share.
• Cadwell Industries: US-based family-owned manufacturer of PSG, EEG, EMG, and IOM systems, with a strong footprint in US sleep labs. Cadwell competes with the Nox A1s in the in-lab PSG segment and shares a similar focus on clinical-grade signal quality and sleep technician workflows.
• Somnomedics: Germany-based manufacturer of PSG and HST systems, including the SOMNOmedics and SOMNOscreen product families. Strong overlap with Nox Medical in European sleep diagnostics, wireless/portable PSG, and home-based testing workflows.
• Cleveland Medical Devices (CleveMed): US-based developer of wireless PSG (SleepScout) and home sleep testing devices. CleveMed's wireless PSG architecture overlaps directly with Nox A1s's Bluetooth body-area-network approach, and the company targets the same hospital-to-home diagnostic workflow.

Broad incumbents

• Philips Respironics: One of the two largest incumbents in sleep diagnostics and therapy, with Alice PSG and HST product lines alongside CPAP/ventilation. Nox competes against Philips for sleep lab contracts and HST procurement; the 2021 CPAP recall created share-shift opportunities for Nox but also consolidated Philips' installed base in PSG.
• ResMed: Global leader in sleep-disordered breathing, primarily in CPAP therapy but with the NightOwl HST and broader digital health ecosystem. ResMed's vertically integrated therapy-plus-diagnostics model and large hospital-channel relationships make it a strategic incumbent competitor for Nox's enterprise customers.

Emerging players

• EnsoData: US-based AI platform that automates sleep study scoring and clinical analysis, competing directly with Nox BodySleep and Noxturnal's AI features in the US market. EnsoData's US-cleared positioning exploits the gap left by BodySleep's unavailability in the US.
• Sunrise (formerly Ectosense): Belgium-based developer of a chin-mounted home sleep testing device (Sunrise) that competes with Nox T3s in European HSAT. Sunrise's consumer-friendly form factor and AI-driven analysis represent an emerging alternative for unattended home sleep diagnostics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/pages/Nox-Medical/198234053544023
• LinkedInlinkedin.com/company/nox-medical

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds11 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nox Medical